PRE-SEED 2026

DrGuido.ai 3.0 evolves from a proven global success: live in 7 interface languages, 100+ dialogue languages, and downloaded worldwide by users seeking medical clarity across borders.
Now it becomes a Personal Health Super-App that organizes, interprets, and connects personal health data — fast, secure, and user-controlled.

Empower everyone to understand, manage, and share their health safely. DrGuido transforms scattered medical data into a unified, intelligent, and privacy-first health ecosystem.

• B2C (Freemium): Free + Premium (€4.97/month) for unlimited data management.
• B2B2C (White-Label): Corporate versions for welfare and healthcare networks.
• Revenue: Subscriptions, enterprise licenses, and APIs.

The AI Health market exceeds $200B by 2030, growing at a CAGR of 35%+. DrGuido leads by connecting language, data, and healthcare for over 1B global migrants needing multilingual access. A validated global user base proves traction and positions DrGuido as the next-generation Personal Health Super-App.

1. Super-App Cloud Platform (Frontend): Patent-pending personal healthcare architecture integrating health data, wearables, and SubApps.
2. AI Doctor Platform (Backend): Patent-pending RAG + LLM Orchestrator trained on anonymized conversations for intelligent health insights.

• Q4 2025: Funding close & setup.
• Q2 2026: Beta release.
• Q4 2026: Initial global rollout & B2B onboarding.
• Q4 2027: 1M users, €500K ARR.

• Pre-Seed: €2M
• Valuation: €8M pre-money
  
• Equity: Founder 80% – Investors 20%
  
• Goal: Global rollout of DrGuido 3.0 and scaling of the AI Doctor backend.

• 30% – Tech Development: Finalize Super-App and AI backend; Beta by Q1 2026.
• 20% – IP & Legal: Patent filings and privacy framework.
• 50% – Growth: Marketing for 1M B2C users and 5+ major B2B clients (>15K employees).

DrGuido is already global, user-validated, and ready to scale. With its proven traction, patentable tech, and user-first design, it defines the future of AI-powered personal health management.